Michal Bitman
- Co-authors
- Zdeněk DvořákRadim VrzalPetr PávekLucie KrausováLucie StejskalováJ BlahošTomáš SmutnýPetr Bachleda
- Topics
- Pharmacogenetics and Drug Metabolism (4 papers)Drug Transport and Resistance Mechanisms (2 papers)Pharmacological Effects and Toxicity Studies (2 papers)
- Partner nations
- Czechia
In The Last Decade
Michal Bitman
6 papers receiving 453 citations
Hit Papers
Peers
Comparison fields: 5 of 103
- Molecular Biology 170
- Pharmacology 78
- Cellular and Molecular Neuroscience 50
- Oncology 50
- Physiology 47
Countries citing papers authored by Michal Bitman
This map shows the geographic impact of Michal Bitman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michal Bitman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michal Bitman more than expected).
Fields of papers citing papers by Michal Bitman
This network shows the impact of papers produced by Michal Bitman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michal Bitman. The network helps show where Michal Bitman may publish in the future.
Co-authorship network of co-authors of Michal Bitman
This figure shows the co-authorship network connecting the top 25 collaborators of Michal Bitman. A scholar is included among the top collaborators of Michal Bitman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michal Bitman. Michal Bitman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 27 | |
| 2 | Rifampicin Does not Significantly Affect the Expression of Small Heterodimer Partner in Primary Human Hepatocytesbreakdown → | 345 |
| 3 | 5 | |
| 4 | 3 | |
| 5 | 46 | |
| 6 | 31 |
About Michal Bitman
Michal Bitman is a scholar working on Pharmacology, Endocrinology, Diabetes and Metabolism and Pediatrics, Perinatology and Child Health, having authored 6 papers that have together received 457 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (4 papers), Drug Transport and Resistance Mechanisms (2 papers) and Pharmacological Effects and Toxicity Studies (2 papers). The work is most often cited by research in Pharmacology (78 citations), Geriatrics and Gerontology (23 citations) and Biological Psychiatry (8 citations). Michal Bitman has collaborated with scholars based in Czechia. Frequent co-authors include Zdeněk Dvořák, Radim Vrzal, Petr Pávek, Lucie Krausová, Lucie Stejskalová, J Blahoš, Tomáš Smutný and Petr Bachleda. Their work appears in journals such as Journal of Thrombosis and Haemostasis, Frontiers in Pharmacology and Toxicology Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.